COSCIENS Biopharma Inc. Quarterly Liabilities in CAD from Q4 2022 to Q4 2023

Taxonomy & unit: ifrs-full: CAD and USD
Summary: COSCIENS Biopharma Inc. quarterly Liabilities history and growth rate from Q4 2022 to Q4 2023.
COSCIENS Biopharma Inc. Liabilities for the quarter ending December 31, 2023 was CA$3.59M, a 34.1% decline year-over-year.

Liabilities, Quarterly (CAD)

Liabilities, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2023	3.59M	-1.85M	-34.1%	Dec 31, 2023	20-F	2025-04-09
Q4 2022	5.45M			Dec 31, 2022	20-F	2025-04-09

* An asterisk sign (*) next to the value indicates that the value is likely invalid.